Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature [Letter].
作者信息
Tatu Alin Laurentiu, Nadasdy Thomas, Bujoreanu Florin Ciprian
机构信息
"St. Parascheva" Clinical Hospital of Infectious Diseases, Dermatology Department, Galati, Romania.
Faculty of Medicine and Pharmacy/Clinical Department, Dermatology, Medical and Pharmaceutical Research Unit/Competitive, Interdisciplinary Research Integrated Platform, ReForm-UDJG, "Dunărea de Jos" University, Galati, Romania.
出版信息
Clin Cosmet Investig Dermatol. 2021 Feb 26;14:185-186. doi: 10.2147/CCID.S305847. eCollection 2021.
Abstract
摘要
相似文献
1
Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature [Letter].炎症和血管损伤作为COVID-19皮肤变化的基础：来自文献的23例患者的初步分析[信函]
Clin Cosmet Investig Dermatol. 2021 Feb 26;14:185-186. doi: 10.2147/CCID.S305847. eCollection 2021.
2
Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.致编辑的信——2019冠状病毒病（COVID-19）患者循环血浆中血管紧张素II和醛固酮水平：初步报告
Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):702-703. doi: 10.1016/j.pcad.2020.07.006. Epub 2020 Jul 10.
3
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).白细胞介素-1（IL-1）在 COVID-19 中诱导血栓烷 A2（TxA2）的产生，导致炎症和微血栓形成：白细胞介素-1 受体拮抗剂（IL-1Ra）的抑制作用。
J Biol Regul Homeost Agents. 2020;34(5):1623-1627. doi: 10.23812/20-34-4EDIT-65.
4
COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?致编辑的关于COVID-19的信：心外膜脂肪炎症是否可能是COVID-19病情加重的因素？
Metabolism. 2021 Apr;117:154722. doi: 10.1016/j.metabol.2021.154722. Epub 2021 Feb 4.
5
[Letter to the Editor Regarding the Article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal"].[致编辑的信：关于文章《新冠疫情期间的超额死亡率估计：来自葡萄牙的初步数据》]
Acta Med Port. 2020 Oct 1;33(10):705. doi: 10.20344/amp.14549. Epub 2020 Aug 19.
6
Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients.COVID-19 患者的血管闭塞是由于内皮细胞和血管平滑肌细胞的生长所致。
Int J Dermatol. 2021 Jan;60(1):73-80. doi: 10.1111/ijd.15300. Epub 2020 Nov 12.
7
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.在住院的 COVID-19 患者中，心脏损伤、炎症和凝血生物标志物与结局的纵向相关性。
J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.
8
Skin and Mucosal Damage in Patients Diagnosed With COVID-19: A Case Report.COVID-19 患者的皮肤和黏膜损伤：病例报告。
J Wound Ostomy Continence Nurs. 2020 Sep/Oct;47(5):435-438. doi: 10.1097/WON.0000000000000690.
9
Letter to the Editor about the Article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal https://doi.org/10.20344/amp.13928".致编辑的信：关于文章《新冠疫情期间的超额死亡率估计：来自葡萄牙的初步数据》https://doi.org/10.20344/amp.13928
Acta Med Port. 2020 Jun 1;33(6):446-447. doi: 10.20344/amp.14032. Epub 2020 May 5.
10
Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid.局部注射促肾上腺皮质激素释放因子可减轻阿霉素诱导的眼睑急性炎症。
Invest Ophthalmol Vis Sci. 1997 Apr;38(5):834-41.
引用本文的文献
1
Teledermatology Practice in a Department that Was Relocated Multiple Times during the COVID-19 Pandemic.在新冠疫情期间多次搬迁的科室中的远程皮肤病学实践。
Clin Cosmet Investig Dermatol. 2024 Feb 14;17:447-449. doi: 10.2147/CCID.S452872. eCollection 2024.
2
Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review).乙肝再激活风险：从银屑病生物治疗到新冠病毒病免疫抑制治疗（综述）
Exp Ther Med. 2022 Jun;23(6):385. doi: 10.3892/etm.2022.11312. Epub 2022 Apr 12.
3
The Role of D-Dimers in the Initial Evaluation of COVID-19.D-二聚体在新型冠状病毒肺炎初始评估中的作用
Ther Clin Risk Manag. 2022 Mar 31;18:323-335. doi: 10.2147/TCRM.S357214. eCollection 2022.
本文引用的文献
1
Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature.炎症和血管损伤作为新冠病毒病皮肤改变的基础：来自文献的23例患者的初步分析
Clin Cosmet Investig Dermatol. 2021 Jan 6;14:1-7. doi: 10.2147/CCID.S278833. eCollection 2021.
2
SARS-CoV-2 in semen: Potential for sexual transmission in COVID-19.精液中的新型冠状病毒2：COVID-19通过性传播的可能性
Int J Surg. 2020 Dec;84:156-158. doi: 10.1016/j.ijsu.2020.11.011. Epub 2020 Nov 13.
3
Familial clustering of COVID-19 skin manifestations.COVID-19 皮肤表现的家族聚集性。
Dermatol Ther. 2020 Nov;33(6):e14181. doi: 10.1111/dth.14181. Epub 2020 Sep 4.
4
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.SARS-CoV-2 刺突受体结合域与 ACE2 受体复合物的结构。
Nature. 2020 May;581(7807):215-220. doi: 10.1038/s41586-020-2180-5. Epub 2020 Mar 30.
5
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.SARS冠状病毒功能性受体ACE2蛋白的组织分布。理解SARS发病机制的第一步。
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
Zotero 插件